Drug Catalog - Product Detail
ORPHENADRINE CITRATE ER TB 100MG 500
| NDC | Mfr | Size | Str | Form |
|---|---|---|---|---|
| 00115-2011-02 | AMNEAL PHARMACEUTICALS | 500 | 100MG | TABLET |
PACKAGE FILES
Generic Name
Substance Name
Product Type
Route
Application Number
Description
DESCRIPTION Orphenadrine citrate is the citrate salt of orphenadrine (2-dimethylaminoethyl-2-methylbenzhydryl ether citrate). It occurs as a white, crystalline powder having a bitter taste. It is practically odorless; sparingly soluble in water, slightly soluble in alcohol. Each orphenadrine citrate extended-release tablet contains 100 mg orphenadrine citrate, USP. Orphenadrine citrate extended-release tablets also contain ethylcellulose NF, povidone USP, lactose monohydrate NF, and magnesium stearate NF.
How Supplied
HOW SUPPLIED Orphenadrine Citrate Extended-release Tablets, 100 mg - Each round, white, convex tablet imprinted with “G” on one side and “2011” on the other side. They are available as follows: Bottles of 100: NDC 0115-2011-01 Bottles of 500: NDC 0115-2011-02 Store at controlled room temperature 15° to 30°C (59° to 86°F). Dispense in tightly-closed, light-resistant container (USP). Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807 124-05 Rev. 01-2019-00
Indications & Usage
INDICATIONS AND USAGE Orphenadrine citrate extended-release tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculo skeletal conditions.
Dosage and Administration
DOSAGE AND ADMINISTRATION Orphenadrine citrate extended-release tablets: Adults - Two tablets per day; one in the morning and one in the evening.